Cargando…
A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by multiple episodes of venous and arterial thromboses or recurrent fetal losses in the presence of antiphospholipid antibodies against β(2)GP1, frequently accompanied by moderate thrombocytopenia. Catastrophic APS (CAPS) is a s...
Autores principales: | Chidharla, Anusha, Syed, Salman B, Chatterjee, Tulika, Tarantino, Michael D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566005/ https://www.ncbi.nlm.nih.gov/pubmed/34744467 http://dx.doi.org/10.2147/JBM.S324873 |
Ejemplares similares
-
Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022) -
36-Year-Old Female with Catastrophic Antiphospholipid Syndrome Treated with Eculizumab: A Case Report and Review of Literature
por: Strakhan, Marianna, et al.
Publicado: (2014) -
Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report
por: Kronbichler, Andreas, et al.
Publicado: (2014) -
Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report
por: Rovere-Querini, Patrizia, et al.
Publicado: (2018) -
Catastrophic Antiphospholipid Syndrome
por: El-Shereef, Rawhya R., et al.
Publicado: (2016)